Robert MacLaren
Corporate Officer/Principal at University of Oxford
Robert MacLaren active positions
| Companies | Position | Start | End |
|---|---|---|---|
| University of Oxford | Corporate Officer/Principal | - | - |
| The Royal College of Surgeons of Edinburgh | Corporate Officer/Principal | - | - |
Career history of Robert MacLaren
Former positions of Robert MacLaren
| Companies | Position | Start | End |
|---|---|---|---|
| NIGHTSTAR THERAPEUTICS PLC | Director/Board Member | 2013-12-31 | - |
| Founder | 2013-12-31 | - | |
| Independent Dir/Board Member | 2013-12-31 | - | |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Director/Board Member | 2013-12-31 | - |
| Founder | 2013-12-31 | - |
Training of Robert MacLaren
| University of Oxford | Doctorate Degree |
| The University of Edinburgh | Undergraduate Degree |
Statistics
International
| United Kingdom | 6 |
Operational
| Director/Board Member | 2 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Consumer Services | 4 |
| Health Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Health Services |
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nightstar Therapeutics Ltd. is a clinical-stage gene therapy. It engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. The company was founded by Robert MacLaren, Miguel Seabra and Matthew During in 2014 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Robert MacLaren
- Experience
